FibroGen (FGEN) Tops Q4 EPS by 30c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. FISV

Go back to FibroGen (FGEN) Tops Q4 EPS by 30c

FibroGen Reports Fourth Quarter and Full Year 2018 Financial Results

February 27, 2019 4:09 PM EST

  Roxadustat Approved in China for Anemia in Dialysis-Dependent CKD Patients

Primary Efficacy Endpoints Met in Seven Phase 3 Roxadustat Studies for U.S./EU

Conference Call Today at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time

SAN FRANCISCO, Feb. 27, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), a leading biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics, today reported financial results for the fourth quarter and full year 2018 and provided an update on the companys recent developments.

... More